Streamlining Anthem (Elevance Health) CGM Prior Auth Workflows

Navigating the complexities of Anthem (Elevance Health) CGM prior auth is critical for timely patient access to continuous glucose monitoring devices and supplies.

For revenue cycle directors and prior authorization coordinators, efficient management of continuous glucose monitor (CGM) prior authorizations with Anthem-licensed plans is essential. This guide outlines the specific submission channels, documentation requirements, and policy considerations to optimize your workflow for devices like Dexcom and Libre, ensuring compliance and reducing administrative burden.

Anthem (Elevance Health) CGM Prior Auth Submission Channels

For continuous glucose monitor *devices*, Anthem-licensed plans primarily direct medical-benefit prior authorization submissions through Availity Essentials, their multi-payer provider workspace. Providers can initiate PA requests, verify member benefits, and upload supporting documentation via Availity. X12 278 transactions are also accepted via clearinghouses for these medical benefit procedures. For CGM *supplies* that may fall under the pharmacy benefit, retail PA routes through CarelonRx's provider PA system and through ePA partners such as CoverMyMeds and Surescripts.

Key Documentation for Continuous Glucose Monitor Authorization

Successful Anthem (Elevance Health) CGM prior auth requires precise clinical documentation. This typically includes detailed records of the patient's diabetes type, evidence of insulin dependence, and often, a history of glucose monitoring. The prescribing provider must clearly articulate the medical necessity, frequently referencing specific clinical criteria outlined in Anthem's medical policies.

Accessing Anthem's CGM Medical Policy and Criteria

Anthem operating companies publish their medical policy and clinical utilization management guideline libraries through provider sites, generally accessible via Availity. Each state-licensed Anthem plan maintains its own medical policy index, aligning with the broader Elevance Health corporate criteria framework, often with state-specific Medicaid and Medicare Advantage variants. For CGM devices, ensure you reference the specific policy number, plan-state context, and effective date relevant to your patient's plan.

Turnaround Times and Compliance Considerations

Anthem-licensed plans' commercial prior authorization timeframes are governed by state insurance regulations, which vary materially across states. For Medicare Advantage, Medicaid managed care (under Anthem Medicaid plans and Wellpoint), CHIP, and QHP-on-FFM lines, Anthem is impacted by CMS-0057-F, which mandates 72-hour standard and 24-hour expedited decision timeframes on a phased compliance timeline. Providers should verify current payer-published service-level targets through the provider portal.

Electronic Prior Authorization (ePA) Capabilities for CGM

Elevance Health, through its Anthem operating companies, has actively participated in Da Vinci Project initiatives and HL7 connectathons, indicating a posture towards FHIR-based electronic prior authorization (ePA). While specific Da Vinci PAS, CRD, and DTR conformance status requires verification of current public disclosures, the pharmacy benefit for CGM supplies leverages established ePA pathways through CoverMyMeds and Surescripts via CarelonRx.

Common Denial Patterns and Appeal Pathways

Anthem CGM prior auth denials are typically returned via X12 277/835 transactions and Availity status updates. Common denial categories include medical necessity, insufficient documentation, or failure to meet specific step therapy requirements (if applicable to associated medications). Appeals for standard medical PA route through the Anthem operating-company appeals process, as detailed in the provider manual. Peer-to-peer reviews are available as part of this process.

Frequently asked questions

How do I submit a CGM prior authorization request to Anthem?

For CGM devices under the medical benefit, submissions are primarily made through Availity Essentials or via X12 278 transactions through a clearinghouse. For CGM supplies that may fall under the pharmacy benefit, requests route through CarelonRx's provider system or through ePA partners like CoverMyMeds and Surescripts.

What documentation is required by Anthem for CGM prior auth?

Anthem typically requires documentation of the patient's diabetes type, evidence of insulin dependence, and a history of glucose monitoring. Clinical notes must support the medical necessity of the continuous glucose monitor, aligning with Anthem's specific medical policy criteria.

Are CGM devices and supplies covered under the medical or pharmacy benefit by Anthem?

CGM *devices* are generally covered under the medical benefit, requiring prior authorization through Availity or X12 278. CGM *supplies* (sensors, transmitters) may fall under either the medical or pharmacy benefit, depending on the specific Anthem plan and state. Pharmacy benefit supplies typically route through CarelonRx or ePA partners.

What are the typical turnaround times for Anthem CGM prior authorization decisions?

Turnaround times for Anthem CGM prior authorizations vary. Commercial plans are subject to state-specific regulations. For Medicare Advantage and Medicaid plans, Anthem is subject to CMS-0057-F, which mandates 72-hour standard and 24-hour expedited decision timeframes. Always verify current service-level targets via the Anthem provider portal.

Can I appeal an Anthem CGM prior authorization denial?

Yes, denials for Anthem CGM prior authorizations can be appealed. The appeal pathway is typically outlined in the Anthem operating company's provider manual. Peer-to-peer reviews are generally available as part of the appeals process to discuss the clinical rationale for the denial.